Přejít k hlavnímu obsahu

Článek v časopise Publikováno 2025

Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances

Autoři

S. Tangallapalli, R. Gundla, K. Paidikondala, Soňa Gurská, N. Rampeesa, S. Anugu, Petr Džubák, Marián Hajdúch, Viswanath Das, N. Katari

RSC Advances 15(55), 47565-47586 (2025)

Citace publikace

TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA, S. GURSKÁ, N. RAMPEESA, S. ANUGU, P. DŽUBÁK, M. HAJDÚCH, V. DAS, N. KATARI: Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. RSC Advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712.